GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q1 2021

SEC EDGAR SourceSEC Filings

Top Holdings63 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

TENET HEALTHCARE CORP

13.7M$713.7M12.1%$17.93+196.35%
10 qtrssince 2018-Q4
Decreased
0

BAUSCH HEALTH COS INC

15.6M$495.6M8.4%$22.22+39.71%
10 qtrssince 2018-Q4
Decreased
0

THE CIGNA GROUP

1.9M$449.4M7.6%$178.50+23.03%
10 qtrssince 2018-Q4
Increased
83

MCKESSON CORP

1.8M$343.4M5.8%$134.99+41.67%
10 qtrssince 2018-Q4
Increased
84

DXC TECHNOLOGY CO

10.6M$330.8M5.6%$47.39-34.28%
10 qtrssince 2018-Q4
Increased
63
TAKTAK
ADR

TAKEDA PHARMACEUTIC-SP ADR

16.1M$294.1M5.0%$18.73-8.27%
9 qtrssince 2019-Q1
Increased
60

AMERISOURCEBERGEN CORP

1.8M$214.2M3.6%$91.34+19.65%
10 qtrssince 2018-Q4
Increased
91

HCA HOLDINGS INC

1.1M$201.6M3.4%$119.49+51.49%
10 qtrssince 2018-Q4
Decreased
0

UNIVERSAL HEALTH SERVICES-B

1.2M$154.6M2.6%$115.43+15.09%
10 qtrssince 2018-Q4
Increased
81

META PLATFORMS INC-CLASS A

491,855$144.9M2.5%$285.69+0.11%
2 qtrssince 2020-Q4
Increased
84

ALPHABET INC-CL A

65,934$136M2.3%$92.93+9.29%
10 qtrssince 2018-Q4
Increased
84
NUANNUANDelisted

NUANCE COMMUNICATIONS INC

3.1M$134.9M2.3%
10 qtrssince 2018-Q4
Increased
68

BOSTON SCIENTIFIC CORP

3.2M$123.6M2.1%$35.28+9.54%
5 qtrssince 2020-Q1
Increased
61

BAXTER INTERNATIONAL INC

1.4M$116.2M2.0%$74.83+3.11%
5 qtrssince 2020-Q1
Increased
76

BROOKDALE SR LIVING INC

18M$109.2M1.9%$6.13+0.90%
10 qtrssince 2018-Q4
Increased
47

FISERV INC

877,447$104.5M1.8%$114.17+5.77%
7 qtrssince 2019-Q3
Increased
73

FMC CORP

859,688$95.1M1.6%$60.86+56.65%
10 qtrssince 2018-Q4
Increased
56

ANTHEM INC

263,633$94.6M1.6%$307.83+10.89%
2 qtrssince 2020-Q4
Increased
63

HUMANA INC

193,938$81.3M1.4%$333.33+22.20%
10 qtrssince 2018-Q4
Increased
56

Butterfly Network, Inc. Class A

4.8M$80.4M1.4%$17.370.00%
1 qtr
New
68
$5.9B
AUM
63
Positions
Q1 2021
Filing
Rating · 3.5
Quarterly Portfolio Change
+20%Q4'19$11.4B-68%Q1'20$3.7B-1%Q2'20$3.6B-12%Q3'20$3.2B+37%Q4'20$4.4B+35%Q1'21$5.9B
Activity profile
$ moved · Q1'21
New20%Increased52%Decreased19%Exited10%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.2 years
<1Q27%1-4Q13%1-2Y17%2Y+43%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $5.9B across 63 positions as of Q1 2021. Top holdings: THC (12.1%), BHC (8.4%), CI (7.6%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q1 2021 Summary

Active quarter - 20 new positions, 11 exits, 28 increased. Top move: COR (INCREASED, conviction 91). Portfolio: $5.9B across 63 positions.

Top holdings by portfolio weight

Total AUM$6B
THC12.09%
BHC8.40%
CI7.61%
MCK5.82%
DXC5.60%
TAK4.98%
COR3.63%
HCA3.42%
UHS2.62%
META2.45%
Other2.30%

Portfolio allocation by GICS sector

Sectors9
Healthcare65.66%
Unknown9.70%
Technology7.94%
Basic Materials4.81%
Communication Services4.80%
Industrials4.16%
Consumer Defensive1.22%
Financial Services0.91%
Consumer Cyclical0.80%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record72
Conviction49
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PAYMENTS INC
Q2 2025 Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON.COM INC
Q3 2025 Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used